| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
51,319 |
50,790 |
$8.58M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
24,543 |
24,374 |
$6.23M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,779 |
9,611 |
$3.19M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,977 |
2,947 |
$407K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,656 |
2,647 |
$265K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,854 |
1,848 |
$250K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,502 |
3,481 |
$205K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,789 |
2,650 |
$172K |
| 71045 |
Radiologic examination, chest; single view |
9,699 |
9,574 |
$141K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
543 |
361 |
$79K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,718 |
8,306 |
$50K |
| 85027 |
|
8,444 |
8,138 |
$48K |
| 81025 |
|
6,177 |
6,153 |
$46K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
929 |
927 |
$45K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
671 |
653 |
$28K |
| 81001 |
|
5,204 |
5,164 |
$28K |
| D9999 |
Unspecified adjunctive procedure, by report |
31 |
31 |
$27K |
| 80053 |
Comprehensive metabolic panel |
2,712 |
2,365 |
$24K |
| 36415 |
Collection of venous blood by venipuncture |
4,751 |
3,213 |
$24K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
432 |
430 |
$21K |
| 62323 |
|
46 |
45 |
$20K |
| 84484 |
|
1,710 |
1,380 |
$19K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,774 |
1,654 |
$13K |
| 71046 |
Radiologic examination, chest; 2 views |
780 |
779 |
$12K |
| 95811 |
|
25 |
25 |
$10K |
| 81003 |
|
2,032 |
2,019 |
$8K |
| 94060 |
|
197 |
197 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
879 |
690 |
$6K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
25 |
25 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
588 |
574 |
$4K |
| 82550 |
|
625 |
568 |
$4K |
| 76000 |
|
173 |
164 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
94 |
94 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
94 |
94 |
$3K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
29 |
29 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
39 |
39 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
37 |
36 |
$2K |
| 83690 |
|
296 |
295 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
34 |
32 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
126 |
101 |
$1K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
14 |
14 |
$1K |
| 97597 |
|
116 |
92 |
$1K |
| 83735 |
|
176 |
135 |
$1K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
235 |
136 |
$868.88 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14 |
14 |
$546.03 |
| 82962 |
|
187 |
102 |
$543.12 |
| 94729 |
|
13 |
13 |
$479.05 |
| 94726 |
|
13 |
13 |
$417.80 |
| 73564 |
|
12 |
12 |
$363.81 |
| 87210 |
|
56 |
55 |
$269.58 |
| 87077 |
|
29 |
24 |
$208.51 |
| 71250 |
|
12 |
12 |
$190.85 |
| 82948 |
|
44 |
26 |
$167.15 |
| 86780 |
|
24 |
24 |
$153.14 |
| 87807 |
|
13 |
13 |
$151.45 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
234 |
226 |
$86.04 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
29 |
29 |
$52.58 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
667 |
666 |
$36.90 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
93 |
92 |
$6.98 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
140 |
133 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
76 |
75 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
42 |
27 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
82 |
79 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
124 |
123 |
$0.00 |
| 94761 |
|
68 |
68 |
$0.00 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
26 |
26 |
$0.00 |